跳至主要内容
临床试验/NCT04883970
NCT04883970进行中(未招募)不适用

CLDN18.2 Targeting 124I-18B10(10L) PET Imaging in Patients With Gastrointestinal Tumors

Peking University Cancer Hospital & Institute1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2021年5月13日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
15
试验地点
1
主要终点
Standardized uptake value(SUV)

研究概览

简要总结

The objective of the study is to constrcut a noninvasive approach 124I-18B10(10L) PET/CT to detect the CLDN18.2 expression of tumor lesions in patients with gastrointestinal tumors and to identify patients benefiting from CLDN18.2 targeting treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged >18 years old; ECOG 0 or 1;
  • Patients with Gastrointestinal tumors;
  • Has at least one measurable target lesion according to Response Evaluation Criteria in Solid Tumors (RECIST V1.1);
  • life expectancy >=12 weeks.

排除标准

  • Significant hepatic or renal dysfunction;
  • Is pregnant or ready to pregnant;
  • Cannot keep their states for half an hour;
  • Refusal to join the clinical study;
  • Suffering from claustrophobia or other mental diseases;
  • Any other situation that researchers think it is not suitable to participate in the experiment.

结局指标

主要结局

Standardized uptake value(SUV)

时间窗: 2 years

次要结局

未报告次要终点

研究者

发起方
Peking University Cancer Hospital & Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hua Zhu

Associate Professor

Peking University Cancer Hospital & Institute

研究点 (1)

Loading locations...

相似试验